Cart
sales@molnova.com
L-Palmitoylcarnitine
CAS No. 2364-67-2
L-Palmitoylcarnitine( —— )
Catalog No. M33400 CAS No. 2364-67-2
L-Palmitoylcarnitine (L-PC) is an important endogenous fatty acid metabolite that inhibits Na/K ATPase activity and potentiates fibrinolytic enzymes and tPA to inhibit thrombosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 459 | Get Quote |
|
| 10MG | 657 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameL-Palmitoylcarnitine
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-Palmitoylcarnitine (L-PC) is an important endogenous fatty acid metabolite that inhibits Na/K ATPase activity and potentiates fibrinolytic enzymes and tPA to inhibit thrombosis.
-
DescriptionL-Palmitoylcarnitine (L-PC) is an important endogenous fatty acid metabolite that inhibits Na/K ATPase activity and potentiates fibrinolytic enzymes and tPA to inhibit thrombosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2364-67-2
-
Formula Weight399.61
-
Molecular FormulaC23H45NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](OC(CCCCCCCCCCCCCCC)=O)(C[N+](C)(C)C)CC([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ATPase-IN-3
ATPase-IN-3 is an ATPase (ATPase) inhibitor that can be used in the study of metabolism-related diseases.
-
Digoxin
Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
